NewLeaf Symbiotics
Latest round
- Series D
Last raised
- Dec 2023
Total raised
- $121M
Investors
- 11
About NewLeaf Symbiotics
Based in the US, NewLeaf Symbiotics, Inc.NewLeaf Symbiotics, Inc. was founded in 2012 in St. Louis, US, specializing in advanced agricultural solutions. The company was established by Steve Kahn, who has a history of innovation in the agricultural sector.NewLeaf Symbiotics specializes in advanced agricultural solutions through its innovative product offerings centered on Pink-Pigmented Facultative Methylotrophs (PPFMs). The company’s primary products include TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, and Terrasym 402 Peanut Biostimulant. These biologicals improve traditional crop management practices, providing benefits such as increased yield and protection against rootworm damage.NewLeaf Symbiotics generates revenue through the sale of its specialized agricultural products, marketed business-to-business to farmers and agricultural retailers. Products such as TS201 and Terrasym biostimulants are priced competitively reflecting their proven performance.In December 2023, NewLeaf Symbiotics, Inc. Future growth initiatives include launching new products designed to enhance crop yields and expanding into new markets with a focus on regions identified for their potential agricultural viability.
Who invested in NewLeaf Symbiotics
11 investors across 6 rounds
See all investors in NewLeaf Symbiotics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NewLeaf Symbiotics
Who invested in NewLeaf Symbiotics?
NewLeaf Symbiotics has 11 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NewLeaf Symbiotics raised?
NewLeaf Symbiotics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did NewLeaf Symbiotics last raise money?
NewLeaf Symbiotics's most recent round on record is a Series D, in Dec 2023.
What does NewLeaf Symbiotics do?
Based in the US, NewLeaf Symbiotics, Inc.
Where is NewLeaf Symbiotics headquartered?
NewLeaf Symbiotics is headquartered in St. Louis, US.
Which VCs invest in companies like NewLeaf Symbiotics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NewLeaf Symbiotics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like NewLeaf Symbiotics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.